<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Pharmaceutical Social Media: Focus on the Patient and Return on Health</title>
	<atom:link href="http://prforpharma.com/2009/11/13/pharmaceutical-social-media-focus-on-the-patient-and-return-on-health/feed/" rel="self" type="application/rss+xml" />
	<link>http://prforpharma.com/2009/11/13/pharmaceutical-social-media-focus-on-the-patient-and-return-on-health/#utm_source=feed&#038;utm_medium=feed&#038;utm_campaign=feed</link>
	<description>Discussions about social media, PR and marketing for pharmaceutical companies</description>
	<lastBuildDate>Wed, 16 May 2012 01:30:52 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Odom Lewis</title>
		<link>http://prforpharma.com/2009/11/13/pharmaceutical-social-media-focus-on-the-patient-and-return-on-health/comment-page-1/#comment-777</link>
		<dc:creator>Odom Lewis</dc:creator>
		<pubDate>Fri, 12 Feb 2010 22:43:48 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=63#comment-777</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;RT @PRforPharma: ROI for pharma SM is gaining steam. Here&#039;s a take from an older but relevant post: http://bit.ly/45OJsT Return on Health, focus on patient.&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">RT @PRforPharma: ROI for pharma SM is gaining steam. Here&#39;s a take from an older but relevant post: <a href="http://bit.ly/45OJsT" rel="nofollow">http://bit.ly/45OJsT</a> Return on Health, focus on patient.</span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Chris Iafolla</title>
		<link>http://prforpharma.com/2009/11/13/pharmaceutical-social-media-focus-on-the-patient-and-return-on-health/comment-page-1/#comment-778</link>
		<dc:creator>Chris Iafolla</dc:creator>
		<pubDate>Fri, 12 Feb 2010 22:43:00 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=63#comment-778</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;ROI for pharma SM is gaining steam. Here&#039;s a take from an older but relevant post: http://bit.ly/45OJsT Return on Health, focus on patient.&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">ROI for pharma SM is gaining steam. Here&#39;s a take from an older but relevant post: <a href="http://bit.ly/45OJsT" rel="nofollow">http://bit.ly/45OJsT</a> Return on Health, focus on patient.</span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Mark</title>
		<link>http://prforpharma.com/2009/11/13/pharmaceutical-social-media-focus-on-the-patient-and-return-on-health/comment-page-1/#comment-528</link>
		<dc:creator>Mark</dc:creator>
		<pubDate>Wed, 13 Jan 2010 16:15:05 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=63#comment-528</guid>
		<description>This ties in nicely with participatory medicine, physician education, and CME. There is a return on health that may be measured in outcomes. Outcomes not just based on treatment but on delivery of knowledge and uptake of that knowledge</description>
		<content:encoded><![CDATA[<p>This ties in nicely with participatory medicine, physician education, and CME. There is a return on health that may be measured in outcomes. Outcomes not just based on treatment but on delivery of knowledge and uptake of that knowledge</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Pharma Social Media: Sea Change or Fad? &#124; PRforPharma</title>
		<link>http://prforpharma.com/2009/11/13/pharmaceutical-social-media-focus-on-the-patient-and-return-on-health/comment-page-1/#comment-434</link>
		<dc:creator>Pharma Social Media: Sea Change or Fad? &#124; PRforPharma</dc:creator>
		<pubDate>Fri, 18 Dec 2009 20:34:15 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=63#comment-434</guid>
		<description>[...] companies need to adopt a philosophy that not only considers Return on Investment, but also Return on Health (ROH).  The job of a marketers has changed from pushing information to engaging in a two-way [...]</description>
		<content:encoded><![CDATA[<p>[...] companies need to adopt a philosophy that not only considers Return on Investment, but also Return on Health (ROH).  The job of a marketers has changed from pushing information to engaging in a two-way [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Genzyme Vial Contamination Offers Insight into Pharma Crisis Communications &#124; PRforPharma</title>
		<link>http://prforpharma.com/2009/11/13/pharmaceutical-social-media-focus-on-the-patient-and-return-on-health/comment-page-1/#comment-176</link>
		<dc:creator>Genzyme Vial Contamination Offers Insight into Pharma Crisis Communications &#124; PRforPharma</dc:creator>
		<pubDate>Tue, 24 Nov 2009 19:59:21 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=63#comment-176</guid>
		<description>[...] is where a concept such as Return on Health (ROH) is particularly useful.  If the patient is at the forefront at all times, including during a [...]</description>
		<content:encoded><![CDATA[<p>[...] is where a concept such as Return on Health (ROH) is particularly useful.  If the patient is at the forefront at all times, including during a [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: KendalLo</title>
		<link>http://prforpharma.com/2009/11/13/pharmaceutical-social-media-focus-on-the-patient-and-return-on-health/comment-page-1/#comment-779</link>
		<dc:creator>KendalLo</dc:creator>
		<pubDate>Sun, 22 Nov 2009 20:04:30 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=63#comment-779</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;@lfespino Great article on focusing your social media efforts on the patient - ROH (Return on Health): http://tinyurl.com/yz7uvg5&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">@lfespino Great article on focusing your social media efforts on the patient &#8211; ROH (Return on Health): <a href="http://tinyurl.com/yz7uvg5" rel="nofollow">http://tinyurl.com/yz7uvg5</a></span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Why Pharma Needs Social Media &#124; PRforPharma</title>
		<link>http://prforpharma.com/2009/11/13/pharmaceutical-social-media-focus-on-the-patient-and-return-on-health/comment-page-1/#comment-137</link>
		<dc:creator>Why Pharma Needs Social Media &#124; PRforPharma</dc:creator>
		<pubDate>Fri, 20 Nov 2009 18:06:24 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=63#comment-137</guid>
		<description>[...] the marketing program of a pharmaceutical company.  We&#8217;ve talked about measures like ROI and Return on Health (ROH). We have made a convincing argument that Health Information Seekers turn to [...]</description>
		<content:encoded><![CDATA[<p>[...] the marketing program of a pharmaceutical company.  We&#8217;ve talked about measures like ROI and Return on Health (ROH). We have made a convincing argument that Health Information Seekers turn to [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ellen Hoenig Carlson</title>
		<link>http://prforpharma.com/2009/11/13/pharmaceutical-social-media-focus-on-the-patient-and-return-on-health/comment-page-1/#comment-780</link>
		<dc:creator>Ellen Hoenig Carlson</dc:creator>
		<pubDate>Tue, 17 Nov 2009 04:26:28 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=63#comment-780</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;@PRforPharma :   Thanks for your comments on my blog today. Love your idea of  Return on Health for pharma SM  http://bit.ly/4n0ppI #fdasm&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">@PRforPharma :   Thanks for your comments on my blog today. Love your idea of  Return on Health for pharma SM  <a href="http://bit.ly/4n0ppI" rel="nofollow">http://bit.ly/4n0ppI</a> #fdasm</span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: jo menat</title>
		<link>http://prforpharma.com/2009/11/13/pharmaceutical-social-media-focus-on-the-patient-and-return-on-health/comment-page-1/#comment-781</link>
		<dc:creator>jo menat</dc:creator>
		<pubDate>Sat, 14 Nov 2009 13:04:28 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=63#comment-781</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;RT @d_hamann: Pharmaceutical Social Media: Focus on the Patient and Return on Health http://bit.ly/4n0ppI&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">RT @d_hamann: Pharmaceutical Social Media: Focus on the Patient and Return on Health <a href="http://bit.ly/4n0ppI" rel="nofollow">http://bit.ly/4n0ppI</a></span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: David Hamann</title>
		<link>http://prforpharma.com/2009/11/13/pharmaceutical-social-media-focus-on-the-patient-and-return-on-health/comment-page-1/#comment-782</link>
		<dc:creator>David Hamann</dc:creator>
		<pubDate>Sat, 14 Nov 2009 13:03:19 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=63#comment-782</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;Pharmaceutical Social Media: Focus on the Patient and Return on Health http://bit.ly/4n0ppI&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">Pharmaceutical Social Media: Focus on the Patient and Return on Health <a href="http://bit.ly/4n0ppI" rel="nofollow">http://bit.ly/4n0ppI</a></span></span></span></p>
]]></content:encoded>
	</item>
</channel>
</rss>

